Literature DB >> 1382561

The translocation (1;14)(p34;q11) in human T-cell leukemia: chromosome breakage 25 kilobase pairs downstream of the TAL1 protooncogene.

Y Xia1, L Brown, J T Tsan, C Y Yang, M J Siciliano, W M Crist, A J Carroll, R Baer.   

Abstract

Nearly 30 percent of patients with T-cell acute lymphoblastic leukemia (T-ALL) exhibit a tumor-specific rearrangement of the TAL1 gene (also called TCL5 or SCL). These rearrangements are generated by either local DNA deletion or a (1;14)(p34;q11) chromosome translocation, and they typically result in structural alterations of the TAL1 transcription unit. In this report we present a molecular characterization of the t(1;14)(p34;q11) from a T-ALL patient. As a consequence of the translocation, TAL1 is transposed from its normal position on chromosome 1 into the T-cell receptor alpha/delta chain locus on chromosome 14. Unlike previous cases, the chromosome 1 breakpoint in this patient did not disrupt the continuity of the TAL1 transcription unit, but instead occurred approximately 25 kilobase pairs (kb) downstream of TAL1. This observation suggests that malignant alteration of TAL1 can be mediated by long-range cis-activating mechanisms that are triggered by DNA rearrangement at a distant site. Genes Chrom Cancer 4:211-216 (1992).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382561     DOI: 10.1002/gcc.2870040304

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  4 in total

1.  Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.

Authors:  J T Cheng; M H Cobb; R Baer
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

2.  The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.

Authors:  Marc R Mansour; Takaomi Sanda; Lee N Lawton; Xiaoyu Li; Taras Kreslavsky; Carl D Novina; Marjorie Brand; Alejandro Gutierrez; Michelle A Kelliher; Catriona H M Jamieson; Harald von Boehmer; Richard A Young; A Thomas Look
Journal:  J Exp Med       Date:  2013-07-15       Impact factor: 14.307

3.  Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.

Authors:  Jean-François Spinella; Pauline Cassart; Chantal Richer; Virginie Saillour; Manon Ouimet; Sylvie Langlois; Pascal St-Onge; Thomas Sontag; Jasmine Healy; Mark D Minden; Daniel Sinnett
Journal:  Oncotarget       Date:  2016-10-04

4.  A third tal-1 promoter is specifically used in human T cell leukemias.

Authors:  O Bernard; O Azogui; N Lecointe; F Mugneret; R Berger; C J Larsen; D Mathieu-Mahul
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.